Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
An Emerging Markets Sponsored Commentary ORLANDO, Fla., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Of late, there has been a bounty of good news issued by Biotricity (OTCQB: BTCY) whose remote medical...
-
ORLANDO, Fla., Aug. 20, 2020 (GLOBE NEWSWIRE) -- For quite some time followers of remote medical biometric technology company Biotricity (OTCQB: BTCY) have been waiting for news of the Company’s...
-
An Emerging Markets News Commentary ORLANDO, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- Remote medical biometric technology company Biotricity (OTCQB: BTCY) dropped year-end guidance on...
-
An Emerging Markets News Commentary ORLANDO, Fla., May 22, 2020 (GLOBE NEWSWIRE) -- Breaking news last night commemorates a very important step for medical technology company Biotricity...
-
ORLANDO, Fla., April 29, 2020 (GLOBE NEWSWIRE) -- It is an egregious understatement to say that COVID-19 has changed the world. For many Americans it is the most impactful event of their lifetimes....
-
ORLANDO, Fla., April 22, 2020 (GLOBE NEWSWIRE) -- At Emerging Markets, we are wisely cautious about companies that all of a sudden have big news in whatever the trend or hot industry of the moment...
-
ORLANDO, Fla., April 08, 2020 (GLOBE NEWSWIRE) -- As government and private institutions race to develop an effective cure for patients infected by COVID-19, two antimalarial drugs--chloroquine and...
-
ORLANDO, Fla., April 08, 2020 (GLOBE NEWSWIRE) -- As government and private institutions race to develop an effective cure for patients infected by COVID-19, two antimalarial drugs--chloroquine and...
-
ORLANDO, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Earlier this week, the medical diagnostic and healthcare tech company opened its fourth quarter earnings book covering the three-month period ending...
-
ORLANDO, Fla., Feb. 10, 2020 (GLOBE NEWSWIRE) -- As the end of February gets near, a growing number of biotech investors are eagerly awaiting Biotricity’s (BTCY) 510(k) filing--an FDA submission for...